Cargando…
Metformin Mitigates Fibrosis and Glucose Intolerance Induced by Doxorubicin in Subcutaneous Adipose Tissue
Doxorubicin (DX) is a chemotherapeutic drug that is used in clinical practice that promotes deleterious side effects in non-tumor tissues such as adipose tissue. We showed that DX leads to extensive damage in adipose tissue via a disruption in 5′-adenosine monophosphate-activated protein kinase (AMP...
Autores principales: | Biondo, Luana A., Batatinha, Helena A., Souza, Camila O., Teixeira, Alexandre A. S., Silveira, Loreana S., Alonso-Vale, Maria I., Oyama, Lila M., Alves, Michele J., Seelaender, Marilia, Neto, José C. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952005/ https://www.ncbi.nlm.nih.gov/pubmed/29867463 http://dx.doi.org/10.3389/fphar.2018.00452 |
Ejemplares similares
-
Doxorubicin modulated clock genes and cytokines in macrophages extracted from tumor-bearing mice
por: Teixeira, Alexandre Abilio S., et al.
Publicado: (2020) -
Endurance Exercise Mitigates Immunometabolic Adipose Tissue Disturbances in Cancer and Obesity
por: Rosa-Neto, José Cesar, et al.
Publicado: (2020) -
Tributyrin in Inflammation: Does White Adipose Tissue Affect Colorectal Cancer?
por: Biondo, Luana Amorim, et al.
Publicado: (2019) -
Impact of Doxorubicin Treatment on the Physiological Functions of White Adipose Tissue
por: Biondo, Luana Amorim, et al.
Publicado: (2016) -
Short treatment of metformin attenuated insulin resistance and hepatic steatosis in obese mice by mechanisms independents of PPAR-alpha
por: Teixeira, Alexandre, et al.
Publicado: (2014)